SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novartis Pharmaceuticals Corporation Receives US FDA Approval for Zortress(R) to Prevent Organ Rejection in Adult Kidney Transplant Recipients